Disrupting a $7B Market: How This Medtech Startup is Positioned for Global Acquisition
When a billion people suffer from a condition with no real solution, the market isn’t just big—it’s waiting for a breakthrough. That’s exactly what Giancarlo Migliori, Co-Founder and Managing Partner of Tinnitech International, set out to change with a first-of-its-kind tinnitus treatment.
In the latest episode, we dive into:
✅ The massive $7B market for tinnitus treatment and why it’s been underserved for so long
✅ How direct-to-consumer marketing and international expansion are shaping Tinnitech’s growth
✅ The role of Big Tech in medtech (and what founders should watch for)
✅ Why Tinnitech is seeking an asset acquisition—and what makes an ideal buyer
If you’re in healthtech, medtech, or life sciences, you won’t want to miss this one.
---
Connect with Giancarlo on LinkedIn and learn more about Tinnitech and the Acufree device.
---
Jennifer Andrews, M.Sc., MBA
Follow & Connect With Jen on LinkedIn
Book: Scientist to CEO: The Marketing Handbook to Help STEM Professionals Grow a Thriving Business
Erica Sosnowski, B.Sc., MBA
Follow & Connect With Erica on LinkedIn